Observational Study of Women With Endometrial Cancer Who Receive the Standard Treatment for Their Disease

Part of paid clinical trials in Hartford, Connecticut.

Sponsor
Memorial Sloan Kettering Cancer Center
Study ID
NCT04291612
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
FEMALE
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Physical exam — OTHER
    Part 2 participants will be prospectively followed clinically for relapse for 30 months from the date of surgery for physical examination at post-ops visits.

Study Details

This study is being done to find out how often endometrial cancer recurs after the standard treatment as well as how often the standard treatment results in a lymphedema.

Key Dates

Start date
Feb 26, 2020
Status verified
Mar 2026
Primary completion
Feb 26, 2027
Completion
Feb 26, 2027

Study Design

Enrollment
1,715 participants (estimated)

Arms

  • Arm: Part 1
    Participants will have endometrioid adenocarcinoma histological diagnosis with planned surgical treatment including hysterectomy in combination with SLN biopsy.
  • Arm: Part 2
    Participants will have undergone surgery and bilateral sentinel lymph node mapping (negative for malignancy)

Primary Outcome Measure

Incidence of pelvic/non-vaginal recurrence at 36 months [ Time Frame: 36 months ]

Central Contacts

Locations (13)

FacilityCityStateZIPSite coordinators
Hartford Healthcare Cancer Institute @ Hartford HospitalHartfordConnecticut06102
Jonathan Cosin, MD
860-826-1101
Miami Cancer Institute Baptist Health South FloridaMiamiFlorida33143
John Paul Diaz, MD
786-596-2000
University of Miami (Data Collection Only)MiamiFlorida33136
Brian Clomovitz, MD
305-243-2233
ADVENTHEALTH (Data collection only)OrlandoFlorida32804
Robert Holloway, MD
407-303-2422
Mayo Clinic (Data Collection and Data Analysis)RochesterMinnesota55905-
Memorial Sloan Kettering Basking Ridge (All protocol activities)Basking RidgeNew Jersey07920
Nadeem Abu-Rustum, MD
212-639-7051
Memorial Sloan Kettering Monmouth (All protocol activities)MiddletownNew Jersey07748
Nadeem Abu-Rustum, MD
212-639-7051
Memorial Sloan Kettering Bergen (All protocol activities)MontvaleNew Jersey07645
Nadeem Abu-Rustum, MD
212-639-7051
Memorial Sloan Kettering Commack (All Protocol Activities)CommackNew York11725
Nadeem Abu-Rustum, MD
212-639-7051
Memorial Sloan Kettering Westchester (All protocol activities)HarrisonNew York10604
Nadeem Abu-Rustum, MD
212-639-7051
Memorial Sloan Kettering Cancer CenterNew YorkNew York10065
Nadeem Abu-Rustum, MD
212-639-7051
Memorial Sloan Kettering Nassau (All protocol activities)Rockville CentreNew York11553
Nadeem Abu-Rustum, MD
212-639-7051
Lehigh Valley Health NetworkAllentownPennsylvania18103
Martin Martino, MD
610-402-3650

Find similar trials in Hartford, CT

By condition
Endometrial cancer
By specialty
OncologyGynecologic oncologyWomen's health
By research site
Hartford Healthcare Cancer Institute @ Hartford Hospital· Hartford, CTMiami Cancer Institute Baptist Health South Florida· Miami, FLUniversity of Miami (Data Collection Only)· Miami, FLADVENTHEALTH (Data collection only)· Orlando, FLMayo Clinic (Data Collection and Data Analysis)· Rochester, MNMemorial Sloan Kettering Basking Ridge (All protocol activities)· Basking Ridge, NJ

Related Studies